the carrier-free 17-123i-heptadecanoic acid ( 2 mci ) in 6 % human serum albumin was injected iv for heart and liver studies on selected patients with cirrhosis ( alcoholic , post-necrotic ) and diabetes .
C0023884
liver
C0023890
cirrhosis